| Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides. | |
| | |
MedLine Citation:
|
PMID: 22187375 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Glucagon is believed to be one of the most important peptides for upregulating blood glucose levels. However, homozygous glucagon-green fluorescent protein (gfp) knock-in mice (Gcg(gfp/gfp): GCGKO) are normoglycemic despite the absence of proglucagon-derived peptides, including glucagon. To characterize metabolism in the GCGKO mice, we analyzed gene expression and metabolome in the liver. The expression of genes encoding rate-limiting enzymes for gluconeogenesis was only marginally altered. On the other hand, genes encoding enzymes involved in conversion of amino acids to metabolites available for the tricarboxylic acid cycle and/or gluconeogenesis showed lower expression in the GCGKO liver. The expression of genes involved in the metabolism of fatty acids and nicotinamide was also altered. Concentrations of the metabolites in the GCGKO liver were altered in manners concordant with alteration in the gene expression patterns, and the plasma concentrations of amino acids were elevated in the GCGKO mice. The insulin concentration in serum and phosphorylation of Akt protein kinase in liver were reduced in GCGKO mice. These results indicated that proglucagon-derived peptides should play important roles in regulating various metabolic pathways, especially that of amino acids. Serum insulin concentration is lowered to compensate the impacts of absent proglucagon-derived peptide on glucose metabolism. On the other hand, impacts on other metabolic pathways are only partially compensated by reduced insulin action. |
| | |
Authors:
|
Chika Watanabe; Yusuke Seino; Hiroki Miyahira; Michiyo Yamamoto; Ayako Fukami; Nobuaki Ozaki; Yoshiko Takagishi; Jun Sato; Tsutomu Fukuwatari; Katsumi Shibata; Yutaka Oiso; Yoshiharu Murata; Yoshitaka Hayashi |
Related Documents
:
|
3011105 - Incorporation of [1-14c]arachidonic and [1-14c]eicosapentaenoic acids into the phosphol... 6501865 - Hypotensive effects in cats caused by horseradish peroxidase mediated by metabolites of... 21111425 - Differentiation of various traditional chinese medicines derived from animal bile and g... 8317305 - Eicosanoid production by the mucosa in inflammatory bowel disease after 5-asa treatment. 1572075 - Quantitative analysis of rat synaptosomes and cerebrum using high-resolution 1h magneti... 9933515 - Nmr-observed phosphate trafficking and polyphosphate dynamics in wild-type and vph1-1 m... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Diabetes Volume: 61 ISSN: 1939-327X ISO Abbreviation: Diabetes Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2011-12-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372763 Medline TA: Diabetes Country: United States |
Other Details:
|
Languages: eng Pagination: 74-84 Citation Subset: AIM; IM |
Affiliation:
|
Corresponding author: Yoshitaka Hayashi, hayashiy@riem.nagoya-u.ac.jp. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Central role for interleukin-2 in type 1 diabetes.
Next Document: Hypothalamic leucine metabolism regulates liver glucose production.